PanGIA Biotech's Innovative Study Utilizes Machine Learning for Prostate Cancer Detection via Urine-Based Biopsy PanGIA Biotech has released a groundbreaking study demonstrating a 97.8% sensitivity for detecting prostate cancer using machine learning with urine biopsies, emphasizing earlier diagnosis.

PanGIA Biotech's Innovative Study Utilizes Machine Learning for Prostate Cancer Detection via Urine-Based Biopsy #United_States #Liquid_Biopsy #Delray_Beach #Prostate_Cancer #PanGIA_Biotech